DNases, Ligases, And RNA Polymerases Market: Global Trends & ChallengesPosted by Mrudula Karmarkar on January 6th, 2023 The global DNases, ligases, and RNA polymerases market size is expected to reach USD 1.28 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.58% from 2022 to 2030. Increasing research and development expenditure is one of the key factors fueling market growth. Furthermore, rising biopharmaceutical production along with a focus on DNA-related innovations is expected to positively impact the global DNases market growth over the forecast period. For instance, in June 2020, Alphazyme and Codexis entered into a strategic partnership to provide novel enzymes for diagnostics and research. DNases have continued to garner a significant market share in recent years owing to factors such as an increase in the adoption of DNA enzymes related to pharmaceuticals, which are essential for the treatment of various chronic disorders and digestive diseases. In addition, developments in the biotechnology and pharmaceutical fields, such as the introduction of genetic and protein engineering, have helped in expanding applications of enzymes, which is expected to offer lucrative growth opportunities in the forecast period. An increase in R&D investments to develop ligases as the target for therapeutic applications in cancer is estimated to drive the segment in the forecast period. In addition, strategic activities by major manufacturers will offer lucrative growth opportunities in the projected period. Other factors augmenting segment growth include advancements in healthcare, increasing demand for modernization in the field of medical academics and life sciences, growing investments by governments to develop genomic technologies, and a surge in the demand for oligonucleotide synthesis by private and public research firms. The COVID-19 pandemic situation has offered lucrative opportunities for RNA polymerase applications. Currently, there are over 150 vaccines and therapeutics that either use mRNA in their production processes or are based on mRNA molecules, which are being assessed for the treatment of a wide range of indications. Many mRNA vaccines are approved for emergency use in many countries across the globe. For instance, Moderna's mRNA-1273 and BioNTech/ Pfizer BNT-162 vaccines have been approved for use across various regions globally. Moreover, there are instances of huge capital investments for the development of mRNA vaccines. For instance, in June 2021, Sanofi declared an investment of around USD 452.12 annually for its mRNA vaccines development center. To Request Sample Copy of this report, click the link: The market is witnessing growth due to the factors such as the increasing demand for gene therapy and cancer immunotherapy and the growing demand for mRNA-based vaccines. Moreover, DNases are critical for inexpensive and sustainable production of novel biocatalysts, leveraged bioprocesses, and cost-efficient product recovery processes. A significant rise in the adoption of ligases for recombinant DNA experiments is also projected to accelerate the growth of the market over the forecast period. Extensive focus on innovation using mRNA and its leveraged production is driving the market along with the demand for mRNA-based vaccine production for COVID-19. DNases, Ligases, And RNA Polymerases Market Report Highlights
Wide applications of DNase in biological activities are expected to drive the market for DNase. DNase is used for the inexpensive and sustainable production of novel biocatalysts, leveraged bioprocesses, and cost-efficient product recovery processes. DNase has beneficial effects on inflammatory diseases. For instance, Recombinant human DNase lowers the viscosity of in lungs and is a helpful therapeutic step in the treatment of cystic fibrosis. The rise in consistent research efforts in life sciences and the rise in the demand for gene therapy across the globe are anticipated to be strong drivers for the market. Ligase is an enzyme that uses adenosine triphosphate to develop bonds, and it is appropriately used in DNA recombinant cloning techniques so as to attach restriction endonuclease fragments. T4 DNA ligase (isolated from E. coli) is the ligase that is usually used in molecular biology applications such as next-generation sequencing and cloning. An increase in research funding to develop ligases to be used as a target for therapeutic applications in cancer is estimated to drive the segment in the forecast period. List of Key Players of Ligases Market
Like it? Share it! More by this author |